{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:32:29Z","timestamp":1791919949937,"version":"4.3.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,3]],"date-time":"2024-05-03T00:00:00Z","timestamp":1714694400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG062387"],"award-info":[{"award-number":["R01AG062387"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008374","name":"Emory University Center for Aids Research","doi-asserted-by":"publisher","award":["P30AI050409"],"award-info":[{"award-number":["P30AI050409"]}],"id":[{"id":"10.13039\/100008374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH128158"],"award-info":[{"award-number":["R01MH128158"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH128872"],"award-info":[{"award-number":["R01MH128872"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.neurot.2024.e00373","type":"journal-article","created":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T08:19:36Z","timestamp":1715674776000},"page":"e00373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The identification of intact HIV proviral DNA from human cerebrospinal fluid"],"prefix":"10.1016","volume":"21","author":[{"given":"Zhan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica D.","family":"Reece","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Roa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Tyor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald R.","family":"Franklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott L.","family":"Letendre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent C.","family":"Marconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert M.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Gavegnano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neurot.2024.e00373_bib1","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1086\/648729","article-title":"Improved virological outcomes in British Columbia concomitant with decreasing incidence of HIV type 1 drug resistance detection","volume":"50","author":"Gill","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00373_bib2","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.chom.2012.07.005","article-title":"As good as it gets? The problem of HIV persistence despite antiretroviral drugs","volume":"12","author":"Sigal","year":"2012","journal-title":"Cell Host Microbe"},{"issue":"5341","key":"10.1016\/j.neurot.2024.e00373_bib3","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1126\/science.278.5341.1295","article-title":"Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy","volume":"278","author":"Finzi","year":"1997","journal-title":"Science"},{"issue":"5341","key":"10.1016\/j.neurot.2024.e00373_bib4","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1126\/science.278.5341.1291","article-title":"Recovery of replication-competent HIV despite prolonged suppression of plasma viremia","volume":"278","author":"Wong","year":"1997","journal-title":"Science"},{"issue":"7751","key":"10.1016\/j.neurot.2024.e00373_bib5","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s41586-019-1027-4","article-title":"HIV-1 remission following CCR5Delta32\/Delta32 haematopoietic stem-cell transplantation","volume":"568","author":"Gupta","year":"2019","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.neurot.2024.e00373_bib6","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJMoa0802905","article-title":"Long-term control of HIV by CCR5 Delta32\/Delta32 stem-cell transplantation","volume":"360","author":"Hutter","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.neurot.2024.e00373_bib7","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.tins.2020.06.007","article-title":"The paradox of HIV blood-brain barrier penetrance and antiretroviral drug delivery deficiencies","volume":"43","author":"Osborne","year":"2020","journal-title":"Trends Neurosci"},{"issue":"7","key":"10.1016\/j.neurot.2024.e00373_bib8","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1093\/cid\/ciu477","article-title":"ING116070: a study of the pharmacokinetics and antiviral activity of dolutegravir in cerebrospinal fluid in HIV-1-infected, antiretroviral therapy-naive subjects","volume":"59","author":"Letendre","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"20","key":"10.1016\/j.neurot.2024.e00373_bib9","doi-asserted-by":"crossref","first-page":"8968","DOI":"10.1128\/JVI.00674-16","article-title":"HIV DNA is frequently present within pathologic tissues evaluated at autopsy from combined antiretroviral therapy-treated patients with undetectable viral loads","volume":"90","author":"Lamers","year":"2016","journal-title":"J\u00a0Virol"},{"issue":"4","key":"10.1016\/j.neurot.2024.e00373_bib10","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/ana.26456","article-title":"Intact HIV proviruses persist in the brain despite viral suppression with ART","volume":"92","author":"Cochrane","year":"2022","journal-title":"Ann Neurol"},{"issue":"4","key":"10.1016\/j.neurot.2024.e00373_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/v15041009","article-title":"Intact proviral DNA analysis of the brain viral reservoir and relationship to neuroinflammation in people with HIV on suppressive antiretroviral therapy","volume":"15","author":"Gabuzda","year":"2023","journal-title":"Viruses"},{"issue":"15","key":"10.1016\/j.neurot.2024.e00373_bib12","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1097\/00002030-199910220-00007","article-title":"HIV mediates a productive infection of the brain","volume":"13","author":"Wiley","year":"1999","journal-title":"Aids"},{"issue":"6","key":"10.1016\/j.neurot.2024.e00373_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008381","article-title":"HIV infects astrocytes in vivo and egresses from the brain to the periphery","volume":"16","author":"Lutgen","year":"2020","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.neurot.2024.e00373_bib14","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3389\/fimmu.2016.00397","article-title":"Targeting the brain reservoirs: toward an HIV cure","volume":"7","author":"Marban","year":"2016","journal-title":"Front Immunol"},{"issue":"7","key":"10.1016\/j.neurot.2024.e00373_bib15","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1128\/jvi.68.7.4643-4649.1994","article-title":"Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences","volume":"68","author":"Power","year":"1994","journal-title":"J\u00a0Virol"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00373_bib16","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/infdis\/jis326","article-title":"Central nervous system viral invasion and inflammation during acute HIV infection","volume":"206","author":"Valcour","year":"2012","journal-title":"J\u00a0Infect Dis"},{"issue":"Suppl 2","key":"10.1016\/j.neurot.2024.e00373_bib17","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1097\/QAD.0000000000002268","article-title":"Presence of Tat and transactivation response element in spinal fluid despite antiretroviral therapy","volume":"33","author":"Henderson","year":"2019","journal-title":"Aids"},{"issue":"5","key":"10.1016\/j.neurot.2024.e00373_bib18","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1086\/650538","article-title":"Discordance between cerebral spinal fluid and plasma HIV replication in patients with neurological symptoms who are receiving suppressive antiretroviral therapy","volume":"50","author":"Canestri","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"14","key":"10.1016\/j.neurot.2024.e00373_bib19","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1097\/QAD.0b013e328355e6b2","article-title":"Cerebrospinal fluid HIV escape associated with progressive neurologic dysfunction in patients on antiretroviral therapy with well controlled plasma viral load","volume":"26","author":"Peluso","year":"2012","journal-title":"Aids"},{"issue":"8","key":"10.1016\/j.neurot.2024.e00373_bib20","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1172\/JCI127413","article-title":"Persistent HIV-infected cells in cerebrospinal fluid are associated with poorer neurocognitive performance","volume":"129","author":"Spudich","year":"2019","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00373_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006112","article-title":"Early antiretroviral therapy is associated with lower HIV DNA molecular diversity and lower inflammation in cerebrospinal fluid but does not prevent the establishment of compartmentalized HIV DNA populations","volume":"13","author":"Oliveira","year":"2017","journal-title":"PLoS Pathog"},{"issue":"48","key":"10.1016\/j.neurot.2024.e00373_bib22","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2210584119","article-title":"Elevation of cell-associated HIV-1 transcripts in CSF CD4+ T cells, despite effective antiretroviral therapy, is linked to brain injury","volume":"119","author":"Suzuki","year":"2022","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00373_bib23","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/ana.25160","article-title":"Expression profiling suggests microglial impairment in human immunodeficiency virus neuropathogenesis","volume":"83","author":"Ginsberg","year":"2018","journal-title":"Ann Neurol"},{"issue":"6","key":"10.1016\/j.neurot.2024.e00373_bib24","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1007\/s13365-016-0458-z","article-title":"Preliminary study of a novel cognitive assessment device for the evaluation of HIV-associated neurocognitive impairment","volume":"22","author":"Anderson","year":"2016","journal-title":"J\u00a0Neurovirol"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00373_bib25","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1055\/s-0034-1372339","article-title":"Neurocognitive assessment in the diagnosis of HIV-associated neurocognitive disorders","volume":"34","author":"Robertson","year":"2014","journal-title":"Semin Neurol"},{"issue":"12","key":"10.1016\/j.neurot.2024.e00373_bib26","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad592","article-title":"An automated virtual reality program accurately diagnoses HIV-associated neurocognitive disorders in older people with HIV","volume":"10","author":"Moore","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.neurot.2024.e00373_bib27","series-title":"Revised Comprehensive norms for an expanded Halstead- Reitan Battery: demographically adjusted neuropsycho- logical norms for African American and Caucasian adults scoring program","first-page":"2004","author":"Heaton","year":"2004"},{"issue":"7","key":"10.1016\/j.neurot.2024.e00373_bib28","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1080\/13803395.2011.559157","article-title":"Demographically corrected norms for african Americans and caucasians on the Hopkins verbal learning test-revised, brief visuospatial memory test-revised, Stroop color and Word test, and Wisconsin card sorting test 64-card version","volume":"33","author":"Norman","year":"2011","journal-title":"J\u00a0Clin Exp Neuropsychol"},{"issue":"5","key":"10.1016\/j.neurot.2024.e00373_bib29","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/13803395.2010.535504","article-title":"Normative data and validation of a regression based summary score for assessing meaningful neuropsychological change","volume":"33","author":"Cysique","year":"2011","journal-title":"J\u00a0Clin Exp Neuropsychol"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00373_bib30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/cid\/ciab212","article-title":"Randomized trial of ruxolitinib in antiretroviral-treated adults with human immunodeficiency virus","volume":"74","author":"Marconi","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"7742","key":"10.1016\/j.neurot.2024.e00373_bib31","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41586-019-0898-8","article-title":"A\u00a0quantitative approach for measuring the reservoir of latent HIV-1 proviruses","volume":"566","author":"Bruner","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00373_bib32","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41467-020-20442-3","article-title":"HIV-1 diversity considerations in the application of the Intact Proviral DNA Assay (IPDA)","volume":"12","author":"Kinloch","year":"2021","journal-title":"Nat Commun"},{"issue":"23","key":"10.1016\/j.neurot.2024.e00373_bib33","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1212\/WNL.0b013e318200d727","article-title":"HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study","volume":"75","author":"Heaton","year":"2010","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.neurot.2024.e00373_bib34","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s11904-017-0355-y","article-title":"The alphabet soup of HIV reservoir markers","volume":"14","author":"Sharaf","year":"2017","journal-title":"Curr HIV AIDS Rep"},{"issue":"1","key":"10.1016\/j.neurot.2024.e00373_bib35","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/infdis\/jiaa718","article-title":"Longitudinal dynamics of intact HIV proviral DNA and Outgrowth virus Frequencies in a cohort of individuals receiving antiretroviral therapy","volume":"224","author":"Falcinelli","year":"2021","journal-title":"J\u00a0Infect Dis"},{"issue":"9","key":"10.1016\/j.neurot.2024.e00373_bib36","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/cid\/ciu585","article-title":"HIV-1 DNA decay dynamics in blood during more than a decade of suppressive antiretroviral therapy","volume":"59","author":"Besson","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.neurot.2024.e00373_bib37","doi-asserted-by":"crossref","first-page":"319","DOI":"10.7326\/M14-1027","article-title":"Antiretroviral-free HIV-1 remission and viral rebound after allogeneic stem cell transplantation: report of 2 cases","volume":"161","author":"Henrich","year":"2014","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.neurot.2024.e00373_bib38","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1080\/00498254.2018.1539278","article-title":"Antiretroviral concentrations and surrogate measures of efficacy in the brain tissue and CSF of preclinical species","volume":"49","author":"Srinivas","year":"2019","journal-title":"Xenobiotica"},{"key":"10.1016\/j.neurot.2024.e00373_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577246","article-title":"Distinct cellular immune properties in cerebrospinal fluid are associated with cognition in HIV-infected individuals initiating antiretroviral therapy","volume":"344","author":"Amundson","year":"2020","journal-title":"J\u00a0Neuroimmunol"},{"issue":"7787","key":"10.1016\/j.neurot.2024.e00373_bib40","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41586-019-1841-8","article-title":"Why and where an HIV cure is needed and how it might be achieved","volume":"576","author":"Ndung'u","year":"2019","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.neurot.2024.e00373_bib41","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1097\/QAD.0000000000003001","article-title":"HIV-1 viral blips are associated with repeated and increasingly high levels of cell-associated HIV-1 RNA transcriptional activity","volume":"35","author":"Suzuki","year":"2021","journal-title":"Aids"},{"key":"10.1016\/j.neurot.2024.e00373_bib42","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3389\/fimmu.2018.00144","article-title":"Blood CXCR3(+) CD4 T cells are enriched in inducible replication competent HIV in aviremic antiretroviral therapy-treated individuals","volume":"9","author":"Banga","year":"2018","journal-title":"Front Immunol"},{"issue":"13","key":"10.1016\/j.neurot.2024.e00373_bib43","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.160267","article-title":"HIV viral transcription and immune perturbations in the CNS of people with HIV despite ART","volume":"7","author":"Farhadian","year":"2022","journal-title":"JCI Insight"},{"issue":"18","key":"10.1016\/j.neurot.2024.e00373_bib44","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.121718","article-title":"Single-cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid during virologically suppressed HIV","volume":"3","author":"Farhadian","year":"2018","journal-title":"JCI Insight"},{"issue":"7","key":"10.1016\/j.neurot.2024.e00373_bib45","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1073\/pnas.1917876117","article-title":"Defective HIV-1 proviruses produce viral proteins","volume":"117","author":"Imamichi","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.neurot.2024.e00373_bib46","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.132997","article-title":"Differential decay of intact and defective proviral DNA in HIV-1-infected individuals on suppressive antiretroviral therapy","volume":"5","author":"Peluso","year":"2020","journal-title":"JCI Insight"},{"issue":"6","key":"10.1016\/j.neurot.2024.e00373_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066188","article-title":"Cellular composition of cerebrospinal fluid in HIV-1 infected and uninfected subjects","volume":"8","author":"Ho","year":"2013","journal-title":"PLoS One"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187874792400059X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187874792400059X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T21:11:29Z","timestamp":1727125889000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187874792400059X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":47,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S187874792400059X"],"URL":"https:\/\/doi.org\/10.1016\/j.neurot.2024.e00373","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The identification of intact HIV proviral DNA from human cerebrospinal fluid","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurot.2024.e00373","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of American Society for Experimental NeuroTherapeutics.","name":"copyright","label":"Copyright"}],"article-number":"e00373"}}